CMC for Biologicals

With a focus on proteins

  • Including an outlook on the new (Draft) ICH Q1, ICH M4Q(R2)
  • In-depth know-how from different perspectives
  • Considerations for the implementation of QbD
  • Certified according to ISO 9001 + 21001
CMC for Biologicals

Online-Seminar

From 1.290,00 € plus VAT
Services & Process

Booking details

Online-Seminar

From 1.290,00 € plus VAT
Services & Process

Get your know-how on creating and maintaining quality data for biotech products in our online training. Including an outlook on the new (Draft) ICH Q1 and ICH M4Q(R2).

Your speakers

Dr. Steffen Groß

Dr. Steffen Groß

Paul-Ehrlich-Institut (PEI),
Langen

Dr Gross has extensive experience in molecular and cell biology. In his current position, he is involved in the assessment of the quality and preclinical issues for…

Dr. Michael Jandke

Dr. Michael Jandke

Independent consultant

Since August 2024, Dr Jandke has been serving as an independent consultant.
Prior to that, he worked at Miltenyi from 2019, where he held responsibility for Regulatory Affairs…

Dr. René Thürmer

Dr. René Thürmer

Expert for Pharmaceutical Quality, Bonn, GERMANY

Dr. René Thürmer studied chemistry at the University of Tübingen, where he obtained his doctorate in 1999. He has been working in a public institution…

What to Expect

  • Regulatory framework: ICH guidelines (including an outlook on the new (Draft) ICH Q1 and ICH M4Q(R2))
  • Essential data for biologics for Module 3
  • Challenges in Module 3: Focus on antibodies, immunoglobulins and recombinant proteins
  • Comparability requirements for changes
  • Critical data: Which data must be included in the dossier, which not?

Who Should Attend

This online training is aimed at specialists and managers in the biopharmaceutical industry who are responsible for creating and maintaining the quality module in the CTD or who make a significant contribution to this.

Especially addressed are the departments of regulatory affairs, medical science, quality assurance and quality control.

Objective of the Event

The requirements for Module 3 of the CTD differ fundamentally for biotech products from those for non-biologics.
During this online training, you will gain knowledge with regard to CMC management specifically for biologicals.

After participating in the seminar, you will be familiar with the ICH guidelines, which form the regulatory framework (including an outlook on the new (Draft) ICH Q1 and ICH M4Q(R2)). You will know which data are required for Module 3 and which significant differences exist to non-biologics. You will know the specifics of the documentation for antibodies, immunoglobulins and recombinant proteins and have been provided with practical solutions. Our experts will discuss the comparability requirements in the event of a change by means of a case study.

Finally, you will work out in the workshop which data is mapped in the dossier and how, and learn how to skilfully avoid common mistakes.

Your Benefit

  • The references to regulatory requirements/guidelines, the overview of required studies that are reviewed by the authorities prior to market authorisation" were extremely helpful for participants last year.
  • "A very good overview of the relevant topics" is how one person would characterise the event to their colleagues.

Programme

9:00 am - 5:30 pm CET - Online training

09:00

Quality dossier biotech medicines: The regulatory framework
Dr Michael Jandke
  • Overview of the regulatory requirements
  • Which institutions are involved in the approval process?
  • Biologics vs. non-biologics: Elementary differences
  • What data are required for Module 3? Among others for:
    • Manufacture, characterisation
    • Reference standards, stability
    • Excipients
  • ATMPs: The specifics

10:30

Bio break

10:45

Challenges in Module 3: Focus on antibodies and immunoglobulins
Dr Steffen Groß
  • Process validation
    • Regulatory requirements (including outlook on the new (Draft) ICH M4Q(R2))
    • Process evaluation and verification
    • Continuous vs. traditional approach
  • Characterisation
    • Potency
    • Contaminants
  • Container Closure Systems
  • Stability (including outlook on the new (Draft) ICH Q1)
  • Implementation "Quality by Design"
    • FMEA tools
    • RTRT (Real Time Release Testing)

12:15

Comparability requirements for changes
Dr Steffen Groß
  • Requirements through the Variation Regulation
  • Case study

13:00

Lunch break

14:00

Challenges in Module 3: Focus on recombinant proteins
Dr René Thürmer
  • Analytics, validation of analytical methods
  • Case studies

15:15

Bio break

15:30

CMC Writing, submission strategy and resource planning
Dr Michael Jandke
  • Common shortcomings in dossier evaluation:Which data must be in the dossier, which not?
  • CMC relevant essentials on the procedural steps of the submission
  • Planning resources within the company
  • Back-up data for Module 3 for the clock stop phase

17:15

Q&As and outstanding questions

17:30

End of online training
09:00

Quality dossier biotech medicines: The regulatory framework

Dr Michael Jandke

  • Overview of the regulatory requirements
  • Which institutions are involved in the approval process?
  • Biologics vs. non-biologics: Elementary differences
  • What data are required for Module 3? Among others for:
    • Manufacture, characterisation
    • Reference standards, stability
    • Excipients
  • ATMPs: The specifics
10:30

Bio break

10:45

Challenges in Module 3: Focus on antibodies and immunoglobulins

Dr Steffen Groß

  • Process validation
    • Regulatory requirements (including outlook on the new (Draft) ICH M4Q(R2))
    • Process evaluation and verification
    • Continuous vs. traditional approach
  • Characterisation
    • Potency
    • Contaminants
  • Container Closure Systems
  • Stability (including outlook on the new (Draft) ICH Q1)
  • Implementation "Quality by Design"
    • FMEA tools
    • RTRT (Real Time Release Testing)
12:15

Comparability requirements for changes

Dr Steffen Groß

  • Requirements through the Variation Regulation
  • Case study
13:00

Lunch break

14:00

Challenges in Module 3: Focus on recombinant proteins

Dr René Thürmer

  • Analytics, validation of analytical methods
  • Case studies
15:15

Bio break

15:30

CMC Writing, submission strategy and resource planning

Dr Michael Jandke

  • Common shortcomings in dossier evaluation:Which data must be in the dossier, which not?
  • CMC relevant essentials on the procedural steps of the submission
  • Planning resources within the company
  • Back-up data for Module 3 for the clock stop phase
17:15

Q&As and outstanding questions

17:30

End of online training

Downloads

Request the documents using our form.

Abbreviations-Drug-Regulatory-Affairs-and-CMC

Further Informations


Modular qualification course to become "Development Experts Biologics"

This seminar is elective module of our qualification course to become a "Development Experts Biologics.

The program structure:

  • You will attend our basic course "Biopharmaceuticals" (day I+II; day III is an elective module)
  • Afterward, you'll participate in 3 additional elective seminar modules (= 3 seminar days), which you'll select individually from the program curriculum
  • You'll receive structured professional development and comprehensive knowledge on topics related to the development and manufacture of biologics
  • You can specialise by selecting seminars tailored to your specific area of focus

For more information (in German language) please feel free to visit our Website


In-house seminars: Advanced training tailor-made!

You are looking for this topic for several employees?
We offer the right solution at your site or in virtual format!

We also offer this seminar as an in-house seminar.

Take advantage of the proven concepts of our open seminars and bring your employees to the same level of knowledge quickly and easily.

We will be happy to send you a non-binding offer.


Benefits of a FORUM Institut training course

FORUM Institut’s all-in-one training platform uses the latest teaching methods.
All our online training courses take place in the Learning Space, our holistic learning environment with many features that promote effective and sustainable learning.

  • Live and interactive learning on our Learning Space training platform
  • A platform with many features: events rooms, chat, course agendas and documents, surveys, workshop rooms and much more
  • Easy surveys with Slido
  • ‘Deluxe’ chat: group chats, one-to-one chats, one-to-one video chats
  • A central repository for documents and media
  • Other services and apps such as Padlet and Mentimeter available directly on the platform
  • The perfect marriage of teaching methods and technology
  • High level of interactivity with plenty of opportunity for questions
  • Continuous support throughout the event to ensure the most effective learning
  • Free technical pre-meeting to start off your training on the right foot


Free pre-meeting and technology check

You can attend one of our pre-meetings and explore our Learning Space free of charge. Registration is not required. You can find available dates for a pre-meeting in your customer portal. Click the green ‘Participate’ button in the pre-meeting in the customer portal and you will be redirected to the Learning Space.

The pre-meeting gives you the opportunity to explore our Learning Space and to familiarise yourself with the technology to start off your online training on the right foot. This is a non-binding offer for all our customers and not a prerequisite for participation. If a pre-meeting date does not suit you but you would still like a technology check, please contact us.

In-house Offers - On-site and Online

We also conduct this seminar exclusively for your company - individually tailored to your requirements, flexible scheduling and available as either on-site or online format. Contact us and we will prepare a customized offer for you.

Request a quote

Customer Testimonials

What satisfied participants say

"Qualifizierte Referenten, praxisorientiert, Fragen werden beantwortet"

Ruth Bemelsmann acora Pharma GmbH

"Guter Überblick, Eingehen auf persönliche Fragen - auch spontan während des Vortrags; ich weiß, wo ich nachschauen muss und was ich vermeiden sollte."

Dr. Thomas Stibora Merz Pharma GmbH & Co. KGaA

"Sehr interessant & aktuell, empfehlenswert, sehr hilfreich, um Kenntnisse wieder aufzufrischen und neues zu lernen, aktuelle Informationen aus den Behörden, sehr gut betreutes Seminar, sehr fachspezifische und auch tiefergehende Themen behandelt, sehr anschaulich gestaltet"

"Kompakter Überblick, gut dargestellt; präzise Beantwortung der Fragen, Dozenten alle sehr freundlich & bemüht alle Fragen zu beantworten"

"Veranstaltung aus meiner Sicht sehr empfehlenswert!; hervorragende fachliche Kompetenz der Referenten; sehr umfangreiche Dokumentation"

"Gute Übersicht, viele Informationen, freundliche Atmosphäre, sehr informativ"

"Griffiger Überblick über die Zulassung von Biologicals"

Dr. Cyril Peter Lonza AG

Our Recommendations

Thema
Dates
Format

Further Information

Qualification course CMC-Specialist in Regulatory Affairs

Qualification course CMC-Specialist in Regulatory Affairs

Our modular qualification courses top seminars, felxible selection and cost savings.

Details
Whitepaper: Stability Testing of Drug Products - Focus: EU and ICH Requirements

Whitepaper: Stability Testing of Drug Products - Focus: EU and ICH Requirements

Stay ahead of proposed regulatory changes in pharmaceutical stability testing. This "practical guide" helps you navigate…

Details
Our rating in 2025

Our rating in 2025

More than 3,700 customers have rated our training courses. Thank you for awarding us 4.4 stars out of 5.

Details

Your Contact Person

We are happy to advise you personally and individually.

Our further education offerings are comprehensive. We are happy to personally match your requirements with our offerings. Let our further education experts advise you and contact us today.
Dr. Birgit Wessels

Dr. Birgit Wessels
Conference Manager
+49 6221 500-652
b.wessels@forum-institut.de